Raiffeisen Bank International AG Has $21.71 Million Stake in Intuitive Surgical, Inc. $ISRG

Raiffeisen Bank International AG cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.9% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 49,428 shares of the medical equipment provider’s stock after selling 13,045 shares during the period. Raiffeisen Bank International AG’s holdings in Intuitive Surgical were worth $21,710,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. Norges Bank purchased a new stake in shares of Intuitive Surgical during the second quarter worth $2,569,260,000. Rakuten Investment Management Inc. acquired a new position in Intuitive Surgical in the third quarter worth approximately $388,436,000. Vanguard Group Inc. lifted its stake in Intuitive Surgical by 2.1% in the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after acquiring an additional 670,302 shares during the last quarter. Jennison Associates LLC grew its position in Intuitive Surgical by 20.4% in the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock worth $1,696,738,000 after acquiring an additional 528,359 shares in the last quarter. Finally, Bessemer Group Inc. raised its holdings in shares of Intuitive Surgical by 89.3% during the 2nd quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock valued at $428,386,000 after purchasing an additional 371,806 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $504.05 on Friday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $607.35. The stock has a market cap of $179.00 billion, a P/E ratio of 63.88, a PEG ratio of 3.87 and a beta of 1.65. The company has a fifty day moving average price of $535.88 and a 200 day moving average price of $510.51.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. During the same period last year, the business earned $2.21 earnings per share. Intuitive Surgical’s quarterly revenue was up 18.8% compared to the same quarter last year. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

ISRG has been the topic of several analyst reports. BTIG Research reissued a “buy” rating and set a $616.00 target price on shares of Intuitive Surgical in a research report on Friday, January 23rd. Daiwa Securities Group raised their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Sanford C. Bernstein lifted their price target on shares of Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research report on Friday, January 23rd. TD Cowen raised shares of Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Finally, HSBC lifted their target price on shares of Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a report on Monday, January 26th. Two analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $617.23.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Gary S. Guthart sold 24,500 shares of the firm’s stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the completion of the transaction, the director owned 3,694 shares in the company, valued at $1,958,189.40. This trade represents a 86.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Myriam Curet sold 421 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $208,378.16. Following the sale, the executive vice president directly owned 409 shares in the company, valued at $202,438.64. The trade was a 50.72% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 56,189 shares of company stock valued at $30,785,441 over the last quarter. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.